graduate companies
- Filter:
- All
- #
- a
- b
- c
- d
- e
- f
- g
- h
- i
- j
- k
- l
- m
- n
- o
- p
- q
- r
- s
- t
- u
- v
- w
- x
- y
- z
149 Medical
AAVPACK
Accurvec Biotech
AChemtek
Acotrix, Inc
Advanced Diagnostic Technologies
Agilux Laboratories
Alpha-Beta Technology, Inc.
Acquisition
Alpha-Beta was the second ever startup company to enter the MBI incubator. Alpha-Beta reached a peak headcount of 220 employees and peak market capitalization of $350 million, before being sold in 1999. Products developed by Alpha-Beta are now marketed as Wellmune by Kerry, a global health and nutrition company.
Learn more
Amachumu Bio
Anteros Bio
We're on a journey to help couples reclaim their intimacy by providing the first at-home genital microbiome test kit for couples that will help answers your questions about recurring UTIs, Yeast Infections, Inflammation, Discomfort and more.
Antigen Express, Inc
Acquired by Generex
Learn more
Antigen Targeting Consulting
Arogy Tx
Astraeus Technologies
Atoxin Biotech LLC
Attogen, Inc
Avatar Pharmaceuticals
Acquired by Vertex Pharmaceuticals
Learn more
Averica Discovery Services Inc
Beckman Coulter
Bio-Detail Corporation
BioChron, LLC
Biocytogen, LLC
IPO, $335M+
Learn more
Bioflash Partners, LLC
Acquired by Repligen
Learn more
BioFluentLabs
Bioheart
Bioinformatics.org
Biolyceum
Biomere
Acquired by JOINN Laboratories Co. Ltd.
Learn more
BioPact
BioTechnic Products LTD
Biotrofix, Inc.
Blue Sky Biotech, Inc
Acquired by Curia
Learn more
Boston Biokeys Corporation
Carepoint Solutions, Inc
Cell Mosaic
CellEdit, LLC
Clock Coach
Coley Pharmaceutical Group, Inc
Acquired by Pfizer
Learn more
Convergent Dental
$115M+ raised, commercialized product
Learn more
Creoptix
Crow’s Nest Bioventures & Greater Good Imperial Brewing, Co.
Cureport
CytoVera, Inc
DermBiont
Leveraging skin microbiome therapeutics to treat, cure, and prevent skin diseases
DNX Resource Group, Inc
ECI Biotech
Edelweiss Immune
Novel therapeutics for autoimmune diseases
Eden Research
Enable Life Sciences
Immuno-oncology CRO services.
Enrich Therapeutics
Entegrion, Inc
EpigenDx
Fluidform
GAMA Therapeutics
Gemini Medical, Inc.
Genome Quest, Inc
Gliese 623B
Medtech Consultancy for Small Businesses
GlycoSolutions Corporation
Grove Instruments, Inc
HDL Therapeutics, Inc.
HelixBind
Histologistics
HSRL, Inc.
Acquired by StageBio
Learn more
Hypromatrix, Inc
Incite Advisors, Inc
Innolign Biomedical
Intelligent Biosystems
Invetx
IPO, $80M+
Learn more
iOmics Corporation
iVexSol
Series A
Learn more
Janus Biotherapeutics
JURA Bio, Inc.
Building CAR-T to fight autoimmunity
JuvoBio Pharmaceuticals
KBioBox, LLC
KeraCure, Inc
Leveragen
Customized and complete genetic modeling services.
LoopCO2
Experts of converting CO2 to plastics
Matrigen Life Technologies
MedTherapy Biotech
MICROBAC
MicroECM
MSM Protein Technologies
MyoSyntax
NanoBio Systems
Nemucore Medical Innovations, Inc
Niagara Biosciences
Nirogyone Therapeutics
NOMIR Medical Technologies
Nyla Laboratories
Acquired
Learn more
Olaf Pharmaceuticals
OptoGlo
OptoGlo has invented an advanced material that is radically changing the functionality of signs. Instantly display messaging and advertising without wires – day or night.
Or-Genix Therapeutics
Ostroff Consulting
Otomagnetics
PackGene Biotech, Inc.
Pananosis
A platform blood-based diagnostic test powered by computationally analyzing immune footprint patterns
Performance Indicator
Pharma Models, LLC
ProFoldin
Propel Biosciences
Provia Labs
Ravissanics, Inc
Robyn Robotics
RXI Pharmaceuticals
Seamless Therapeutics
Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner.
Solarea Bio
Solarea Bio is a biotech company building solutions for health disorders using bacteria and fungi native to healthy foods to create powerful synergistic, anti-inflammatory microbial assemblages.
Spring Bank Technologies
Stability Health
Stryker Orthobiologics
Suco, LLC
Sufacine Development Company
T2 Biosystems
Targeted Biosciences, Inc.
Tarpon Biosystems, Inc
Tech Acquisition by Pall
Learn more
Technical Innovation Center
Time Bioscience
TransCode Therapeutics
IPO, $7M
Learn more
TransCytos
uBriGene
uBriGene Bioscience Inc. is a leading contract development and manufacturing organization (CDMO), specializing in the development and application of cell and gene therapy technologies.
VecX Biomedicines
VecX Biomedicines is an AI-driven biotech company existing at the intersection of computational protein design, bioengineering, synthetic biology, and medicine and pioneering gene therapy to create breakthrough medicines.